This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| NatWest Group | 697.8 | 2.3% |
| Lion Finance Group | 13,670.0 | 2.2% |
| Barclays | 493.8 | 1.9% |
| Endeavour Mining | 4,593.0 | 1.9% |
| Lloyds Banking Group | 111.2 | 1.9% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| London Stock Exchange Group | 8,238.0 | -3.2% |
| Sage Group | 958.0 | -2.2% |
| Smith & Nephew | 1,008.5 | -1.7% |
| Next | 14,685.0 | -1.5% |
| BAE Systems | 1,898.0 | -1.3% |
| Major World Indices | Price | % Chg | 1 Year |
| UK100 INDEX | 10,650 | 0.4% | 14.7% |
| DOW JONES INDUS. AVG | 52,573 | 1.0% | 14.7% |
| DAX INDEX | 25,569 | 0.8% | 7.9% |
| NIKKEI 225 | 63,610 | 0.6% | 42.1% |
| S&P/ASX 200 INDEX | 8,750 | 0.1% | 1.3% |
| Commodity | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 102.36 | 2.31% |
| Brent Crude (ICE) | USD/bbl. | 106.81 | 2.10% |
| Gold Spot | USD/t oz. | 4,331 | 0.4% |
| Copper (Comex) | USd/lb. | 648 | 1.1% |
Click graph to enlarge
The UK 100 is called to open +17 points at at 10,667. The UK 100 is to open higher on Monday, though European peers are to decline, as oil prices register another surge.
The UK 100 is called to open 17.0 points higher, 0.2%, at 10,667.44 on Monday. The index of London large-caps ended up 41.52 points, 0.4%, at 10,650.44 on Friday. Nonetheless, the large-cap benchmark fell 1.7% over the course of last week. It was its worst week since July.
In Tokyo on Monday, the Nikkei 225 was down 1.1%. In China, the Shanghai Composite was 0.1% lower, while the Hang Seng Index in Hong Kong added 0.5%. Sydney’s S&P/ASX 200 was up 0.1%.
AstraZeneca said its new breast-cancer pill missed the key goal of slowing the disease from worsening in a late-stage clinical trial. The U.K. drugmaker evaluated its Etcamah medicine, in combination with Pfizer’s PFE 0.25%increase; up pointing triangle Ibrance, as a first-line treatment for patients with a type of advanced breast cancer that hadn’t received any systemic treatment for advanced disease, it said late Friday. The drug combination showed a numerical improvement in delaying signs that patients’ cancer worsened compared with the standard therapy, but it wasn’t enough to be considered statistically significant, AstraZeneca said.
.
UK
No noteworthy announcements
US
No noteworthy announcements
UK
Kier Group (KIE) – Full Year Results
MJ Gleeson (GLE) – Full Year Results
US
No noteworthy announcements
No noteworthy announcements
UK 100 companies going ex-dividend on 17th September 2026:
None
UK 250 companies going ex-dividend on 17th September 2026:
Foresight Group Holdings
Rank Group
Unite Group
Goodwin
Bridgepoint Group
PPHE Hotel Group
Costain Group
Energean
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.